PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 77 filers reported holding PLIANT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $240 | -73.0% | 22,282 | -62.7% | 0.00% | -100.0% |
| Q1 2024 | $889 | -12.0% | 59,670 | +7.0% | 0.00% | 0.0% |
| Q4 2023 | $1,010 | +15.2% | 55,748 | +10.2% | 0.00% | 0.0% |
| Q3 2023 | $877 | -0.9% | 50,575 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $885 | +47.7% | 48,850 | +117.1% | 0.00% | 0.0% |
| Q1 2023 | $599 | +52.4% | 22,500 | +10.6% | 0.00% | 0.0% |
| Q4 2022 | $393 | -99.9% | 20,350 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | +84.2% | 19,500 | -29.4% | 0.00% | – |
| Q2 2022 | $221,000 | -28.0% | 27,613 | -36.9% | 0.00% | – |
| Q1 2022 | $307,000 | -27.1% | 43,771 | +40.5% | 0.00% | – |
| Q4 2021 | $421,000 | +52.5% | 31,149 | +90.5% | 0.00% | – |
| Q3 2021 | $276,000 | -56.3% | 16,353 | -24.6% | 0.00% | -100.0% |
| Q2 2021 | $632,000 | -14.0% | 21,691 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $735,000 | +240.3% | 18,700 | +96.8% | 0.00% | – |
| Q4 2020 | $216,000 | +300.0% | 9,500 | +295.8% | 0.00% | – |
| Q3 2020 | $54,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
| TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
| Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
| GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
| First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
| Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
| Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
| Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
| Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
| Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |